https://doi.org/10.18632/oncotarget.20082
X
Xiaohu Meng
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
25
Papers
333
Citations
6
h-index
5
i10-index
Xiaohu Meng is an academic researcher from Westlake University. The author has contributed to research in topics: Mesenchymal stem cell research & Peripheral Artery Disease Management & Aortic aneurysm repair treatments. The author has an h-index of 6, co-authored 22 publications.
ORCID: 0000-0001-8093-9314Papers by this author
worksIdentification of core genes and outcome in gastric cancer using bioinformatics analysis
2017 · Oncotarget · 116 citations
The differentiation of mesenchymal stem cells to vascular cells regulated by the HMGB1/RAGE axis: its application in cell therapy for transplant arteriosclerosis
2018 · Stem Cell Research & Therapy · 46 citations
https://doi.org/10.1186/s13287-018-0827-z
HMGB1-modified mesenchymal stem cells attenuate radiation-induced vascular injury possibly via their high motility and facilitation of endothelial differentiation
2019 · Stem Cell Research & Therapy · 31 citations
https://doi.org/10.1186/s13287-019-1197-x
Modification of mesenchymal stem cells by HMGB1 promotes the activity of Cav3.2 T-type calcium channel via PKA/β-catenin/γ-cystathionase pathway
2022 · Stem Cell Research & Therapy · 7 citations
https://doi.org/10.1186/s13287-021-02677-z
RETRACTED: The efficacy and safety of non‐surgical treatment of diabetic foot wound infections and ulcers: A systemic review and meta‐analysis
2024 · International Wound Journal · 2 citations
https://doi.org/10.1111/iwj.14615
Additional file 1 of Modification of mesenchymal stem cells by HMGB1 promotes the activity of Cav3.2 T-type calcium channel via PKA/β-catenin/γ-cystathionase pathway
2022 · Figshare · 0 citations
https://doi.org/10.6084/m9.figshare.18132403
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat